Fed. Circ. Faults PTAB Ax Of Patent On Bausch Eye Drops

By Ryan Davis · July 1, 2025, 12:27 AM EDT

The Federal Circuit ruled Monday that the Patent Trial and Appeal Board wrongly invalidated all the claims of a patent that Bausch & Lomb licenses for its Lumify eye drops, saying...

To view the full article, register now.

Documents

Case Information

Case Title

Eye Therapies, LLC v. Slayback Pharma LLC

Case Number

23-2173

Court

Appellate - Federal Circuit

Nature of Suit

- 

Date Filed

July 24, 2023